Year-end Sale % OFF 
Abstract
Alkaloids and triterpenes of Simarouba glauca (Laxmitaru) are known to inhibit the growth of cancers. We have earlier characterized tricaproin (TCN) from this plant and demonstrated its efficacy against CRC cells. Presently, TCN arrested CRC cells in G0/G1 phase in cell cycle analysis and increased the expression of p21 protein. Intra-peritoneal administration of TCN dose dependably inhibited Dalton’s lymphoma ascites tumor growth (2.6 fold) and increases the life span (60%) in Swiss albino mice by reducing Histone deacetylase (HDAC) and increasing caspase-3 mediated apoptosis in tumour tissues. Immunohistochemical details of TCN treated tumour tissues revealed down regulation of markers for angiogenesis progression (Ki67) and cell proliferation (CD31). Together, TCN inhibits tumour development by inducing apoptosis and arresting cells in G0/G1. In conclusion, the result suggests that the Tricaproin from Simarouba glauca is a potent anti-cancer agent to consider for further development.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
